Peter Diamandis, MD — Elevian Co-Founder; xPrize, Singularity U, Celularity, Human Longevity Inc.

Dr. Diamandis is a pioneer in the fields of innovation, commercial space and longevity. In 2014 he was named one of "The World’s 50 Greatest Leaders" – by Fortune Magazine. Diamandis is Founder and Executive Chairman of the XPRIZE Foundation. Diamandis is also the Co-Founder and Vice-Chairman of Human Longevity, Inc. (HLI) and Celularity, genomics diagnostic and cell therapy-based therapeutics companies focused on extending the healthy human lifespan. He is also the Co-Founder and Executive Chairman of Singularity University, a graduate-level Silicon Valley institution that studies exponentially growing technologies, their ability to transform industries and solve humanity’s grand challenges. Diamandis is the New York Times Bestselling author of Abundance – The Future Is Better Than You Think and BOLD – How to go Big, Create Wealth & Impact the World. He earned an undergraduate degree in Molecular Genetics and a graduate degree in Aerospace Engineering from MIT, and received his M.D. from Harvard Medical School.